종목/NXPL
NextPlat Corp
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, Asia and Pacific, and Africa. It operates through two segments, e-Commerce Operations and Healthcare Operations. The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, medication adherence packaging, contracted pharmacy services, health practice risk management, disease testing, contracted pharmacy, and vaccinations services, as well as supplies prescription medications. It also operates e-commerce websites, as well as third-party e-commerce storefronts that provide mobile satellite services solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and internet of things connectivity services; voice, data communications, internet of things (IoT), and machine-to-machine services; tracking and monitoring services; satellite communications products; GPS enabled emergency locator distress beacons; satellite tracking devices used to monitor the location, movements, and history of anything that moves; and GTCTrack, a subscription-based mapping and tracking portal that provides a universal and hardware-agnostic, cloud-based data visualization and management platform. In addition, the company provides value-added services, such as prior authorization assistance, same-day home-medication delivery, on-site provider consultation services, primary care reporting and analytics, and customized packaging solutions. Further, it offers satellite phones, tracking devices, broadband terminals, messaging plans, and connectivity services. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp was founded in 2008 and is headquartered in Hallandale Beach, Florida.
| 발표일 | 분기 | EPS 예상 | EPS 실제 | Surprise | 매출 실제 | 발표 직후 반응 |
|---|---|---|---|---|---|---|
| 3월 31일 (화) | 2025 Q4 | — | $-0.24 | — | $13M | ▼ −21.3% |
| AVGO | 브로드컴 | 1.97T | +1.3% | 100% (4/4) |
| MU | 마이크론 | 896B | +33.2% | 100% (4/4) |
애널리스트 의견이 수집되지 않았습니다.